NCT00087763View on ClinicalTrials.gov

Pegaptanib Sodium on Foveal Thickening in Patients With Exudative Subfoveal Age-Related Macular Degeneration (AMD)

PHASE2CompletedINTERVENTIONAL
Enrollment

135

Participants

Timeline

Start Date

March 31, 2004

Study Completion Date

May 31, 2006

Conditions
Macular Degeneration
Interventions
DRUG

Macugen ™ (pegaptanib sodium injection)

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

Eyetech Pharmaceuticals

INDUSTRY